483
Diwakar Davar, M.D.Diwakar Davar, M.D. – FDA 483, Oct 19, 2023
Record Details
Diwakar Davar, M.D., a Sponsor-Investigator in Pittsburgh, PA, was cited for significant deficiencies related to Institutional Review Board (IRB) oversight during clinical studies. The inspection revealed that research activities continued during a lapse in IRB approval and that changes to a study protocol were implemented without prior IRB approval. These findings indicate a failure to ensure proper ethical and regulatory review of clinical research.
- Person
View Company Profile
ID · a4b080ec-fb6d-49c5-8b55-676890677bd0
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.